Glenmark subsidiary gets 3 ANDA approvals, stock up

MUMBAI: Glenmark Generics Inc, a subsidiary of Glenmark Pharmaceuticals, has received three ANDA approvals by the USFDA for Indomethacin 25mg and 50mg capsules, USP and Sulfamethoxazole and Trimethroprim double and single strength tablets.

The stock was at Rs 355.25, up 1.59 per cent on the BSE. It touched a high of Rs 357.80 and low of Rs 350.10 intraday on volume of 31000 shares.